ʻO ka hāʻawi ʻana i nā mea maʻi me ka ʻeha hope a me ka osteoarthritis (OA) i ka cannabis lapaʻau hiki ke hōʻemi a hoʻopau paha i ka hoʻohana ʻana i nā opioids no ka mālama ʻana i ka ʻeha, e like me nā haʻawina ʻelua i hōʻike ʻia ma ka 2022 Annual Meeting of the American Academy of Orthopedic Surgeons (AAOS). Alakaʻi ʻia e ka mea noiʻi nui ʻo Asif M. Ilyas, MD, MBA, FAAOS, ua hōʻike pū nā haʻawina i ka maikaʻi o ka ʻeha a me ka maikaʻi o nā helu ola ma hope o ka hōʻoia ʻana o nā maʻi no ka cannabis lapaʻau.

He kanalima miliona ʻAmelika i loaʻa i ka ʻeha mau ʻaʻole pili i ka maʻi kanesa, i mālama pinepine ʻia me nā opioids. Eia nō naʻe, pono nā lāʻau lapaʻau ʻē aʻe. Ma 2019, ma kahi o 10.1 miliona mau kānaka he 12 a ʻoi paha i hoʻohana hewa i ka opioids ma 2019, ii a me ka addiction opioid e mau nei i kahi kiʻekiʻe. Ua noiʻi ʻia ka hoʻohana ʻana i ka cannabis lapaʻau ma ke ʻano he lāʻau lapaʻau ʻē aʻe i ka opioids, akā pono nā noiʻi hou aʻe e loiloi i ka hopena, dosing, a pehea e hoʻopilikia ai i ka hoʻohana ʻana i ka opioid no ka mālama ʻana i ka ʻeha.

"I ka hoʻonohonoho ʻana o ka pilikia opioid i kēia manawa, pono mākou e ʻike i nā mea ʻē aʻe e hiki ke hoʻēmi i ka hilinaʻi ʻana i nā opioids no ka hoʻomalu ʻana i ka ʻeha," wahi a Kauka Ilyas, ka luna o ka papahana o ka lima a me nā ʻokiʻoki kiʻekiʻe ma Rothman Orthopedic Institute a me ke kaukaʻi o ka orthopedic surgery. ma Thomas Jefferson University Hospital ma Philadelphia. "I kēia manawa, ʻaʻole mākou e kākoʻo no ka hoʻohana maʻamau o ka cannabis lapaʻau a ʻōlelo paha he koho maikaʻi loa ia, akā hōʻike kā mākou mau haʻawina i ka hiki."

Hoʻohana ʻia ka lāʻau Cannabis i ka ʻeha hope a me nā maʻi OA

Ua nānā nā haʻawina ʻelua i ka ʻikepili o nā ʻōlelo aʻoaʻo opioid i hoʻopiha ʻia no nā poʻe maʻi me ka ʻeha hope a me ka OA i hōʻoia ʻia no ka loaʻa ʻana o ka cannabis lapaʻau ma waena o Pepeluali 2018 a me Iulai 2019. ʻO ka awelika morphine milligram equivalents (MME) i kēlā me kēia lā o nā ʻōlelo opioid i hoʻopiha ʻia i ʻeono mahina ma mua o ke komo ʻana. ua hoʻohālikelike ʻia i ka cannabis lapaʻau i nā mahina ʻeono ma hope o ka loaʻa ʻana o nā mea maʻi.

Ua hōʻike ʻia ka ʻikepili ʻeha hope o ka musculoskeletal non-cancer:

• He emi nui o ka MME awelika holoʻokoʻa i kēlā me kēia lā ma hope o ke kau ʻana i ka cannabis lapaʻau, mai 15.1 a i 11.0 (n=186).

• 38.7% o nā maʻi i hāʻule i ka zero MME i kēlā me kēia lā.

• ʻO nā poʻe maʻi i hoʻomaka ma lalo o 15 MME i kēlā me kēia lā a ʻoi aku ka nui ma mua o 15 MME i kēlā me kēia lā ua emi nui, mai 3.5 a 2.1 (n=134) a me 44.9 a 33.9 (n=52). ʻO nā pākēneka o nā maʻi i hāʻule i ka MME ʻole i kēlā me kēia lā i kēia mau pūʻulu he 48.5% a me 13.5%, kēlā me kēia.

• Ke hoʻohālikelike ʻia me ka papa kuhikuhi (ʻekolu, ʻeono, a me ʻeiwa mau mahina), hōʻike nā maʻi i ka hoʻomaikaʻi ʻana i ka ikaika, ka pinepine, a me ka hana o kēlā me kēia lā ma hope o ka hoʻohana ʻana i ka cannabis lapaʻau.

• Ua hōʻike ka poʻe maʻi i hoʻohana i ʻelua a ʻoi aku paha nā ala o ka hoʻokele no ka cannabis lapaʻau i ka emi nui o ka MME i kēlā me kēia lā, mai 13.2 a 9.5 (n=76).

No ka mālama ʻana i ka OA, ua loiloi ʻia nā ana hopena maʻi i ʻekolu, ʻeono, a me ʻeiwa mau mahina ma hope o ka hoʻohana ʻana i ka cannabis lapaʻau. Ma hope o ke komo ʻana i ka cannabis lapaʻau, ua hōʻike ka haʻawina:

• Ua emi nui ka MME awelika o ka lā o nā palapala kauoha i hoʻopiha ʻia e nā maʻi, mai 18.2 a i 9.8 (n=40). ʻO ka awelika hāʻule i MME i kēlā me kēia lā he 46.3%.

• ʻO ka pākēneka o nā maʻi i hāʻule i ka zero MME i kēlā me kēia lā he 37.5%.

• Ua emi nui na helu eha o na ma'i, mai 6.6 (n=36) a i 5.0 (n=26) a me 5.4 (n=16), ma ekolu a me eono mahina.

• Ua hoʻonui nui ʻia ka maikaʻi o ke ola kino honua, mai 37.5 a i 41.4, i ʻekolu mahina.

"Ke hōʻike nei kā mākou mau haʻawina e hiki i ka cannabis lapaʻau ke hana maikaʻi no ka ʻeha hope a me ka osteoarthritis, hiki ke kōkua i ka hōʻemi ʻana i ka hilinaʻi ʻana i nā opioids," wahi a Dr. Ilyas. "Akā naʻe, pono ka noiʻi hou e hoʻomaopopo maikaʻi i nā ala maikaʻi loa a me nā alapine, nā hanana ʻino, a me nā hopena lōʻihi o ka hoʻohana ʻana i ka cannabis lapaʻau. I ka manawa pōkole, pono e hoʻohana nā mea kākau i ka hoʻoholo like ʻana me kā lākou poʻe maʻi i ka wā e noʻonoʻo ai i ka cannabis lapaʻau no nā maʻi ʻeha musculoskeletal mau loa.

He aha e lawe ʻia mai kēia ʻatikala:

Providing patients with chronic back pain and osteoarthritis (OA) access to medical cannabis can reduce or even eliminate the use of opioids for pain management, according to two studies presented at the 2022 Annual Meeting of the American Academy of Orthopaedic Surgeons (AAOS).
The use of medical cannabis has been researched as an alternative therapy to opioids, but further studies are needed to review efficacy, dosing, and how it can affect opioid use for pain management.
“At this point, we are not advocating for the routine use of medical cannabis or saying it is a better option, but our studies show potential.